GB0327740D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0327740D0
GB0327740D0 GBGB0327740.7A GB0327740A GB0327740D0 GB 0327740 D0 GB0327740 D0 GB 0327740D0 GB 0327740 A GB0327740 A GB 0327740A GB 0327740 D0 GB0327740 D0 GB 0327740D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0327740.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0327740.7A priority Critical patent/GB0327740D0/en
Publication of GB0327740D0 publication Critical patent/GB0327740D0/en
Priority to PCT/EP2004/013416 priority patent/WO2005051916A1/en
Priority to CA002547444A priority patent/CA2547444A1/en
Priority to RU2006122959/04A priority patent/RU2006122959A/ru
Priority to KR1020067010371A priority patent/KR20060103322A/ko
Priority to BRPI0417029-6A priority patent/BRPI0417029A/pt
Priority to JP2006540389A priority patent/JP2007512285A/ja
Priority to EP04819223A priority patent/EP1687279A1/en
Priority to CNA2004800410778A priority patent/CN1906170A/zh
Priority to AU2004293179A priority patent/AU2004293179A1/en
Priority to US10/580,640 priority patent/US20070275948A1/en
Priority to TW093136389A priority patent/TW200528433A/zh
Priority to ARP040104393A priority patent/AR046719A1/es
Priority to ZA200600378A priority patent/ZA200603781B/xx
Priority to IL175663A priority patent/IL175663A0/en
Priority to MA29055A priority patent/MA28177A1/fr
Priority to IS8500A priority patent/IS8500A/xx
Priority to NO20062970A priority patent/NO20062970L/no
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
GBGB0327740.7A 2003-11-28 2003-11-28 Novel compounds Ceased GB0327740D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GBGB0327740.7A GB0327740D0 (en) 2003-11-28 2003-11-28 Novel compounds
CA002547444A CA2547444A1 (en) 2003-11-28 2004-11-25 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics
CNA2004800410778A CN1906170A (zh) 2003-11-28 2004-11-25 用作抗精神病药的7－[4－(4－氯苄氧基)苯磺酰基]－8－甲氧基－3－甲基－2,3,4,5－四氢－1h－3－苯并氮杂䓬鎓马来酸盐或甲苯磺酸盐
US10/580,640 US20070275948A1 (en) 2003-11-28 2004-11-25 7-[4-(4-Chlorobenzyloxy)Benzenesulfonyl]-8-Methoxy-3-Methyl-2,3,4,5-Tetrahydro-1h-3-Benzazepinium Maleate Or Tosylate As antipyschotics
RU2006122959/04A RU2006122959A (ru) 2003-11-28 2004-11-25 Малеат или тозилат 7-[4-(4-хлорбензилокси)бензолсульфонил]-8-метокси-3-метил-2,3,4,5-тетрагидро-1h-бензазепиния в качестве антипсихотических средств
KR1020067010371A KR20060103322A (ko) 2003-11-28 2004-11-25 항정신병제로서의7-[4-(4-클로로벤질옥시)벤젠술포닐]-8-메톡시-3-메틸-2,3,4,5-테트라히드로-1ｈ-3-벤즈아제피늄 말레에이트 또는토실레이트
BRPI0417029-6A BRPI0417029A (pt) 2003-11-28 2004-11-25 malaeto ou tosilado de 7-[4-(4-clorobenzilóxi) benzenossulfonil]-8-metóxi-3-metil-2,3,4,5-tetraidro- 1h-3-benzazepìnio como antipsicótico
JP2006540389A JP2007512285A (ja) 2003-11-28 2004-11-25 抗精神病薬としての７−［４−（４−クロロベンジルオキシ）ベンゼンスルホニル］−８−メトキシ−３−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピニウムマレエートもしくはトシレート
EP04819223A EP1687279A1 (en) 2003-11-28 2004-11-25 7- [4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics
PCT/EP2004/013416 WO2005051916A1 (en) 2003-11-28 2004-11-25 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics
AU2004293179A AU2004293179A1 (en) 2003-11-28 2004-11-25 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepinium maleate or tosylate as antipsychotics
TW093136389A TW200528433A (en) 2003-11-28 2004-11-26 Novel compounds
ARP040104393A AR046719A1 (es) 2003-11-28 2004-11-26 Sales de benzazepina y composiciones farmacéuticas que las contienen.
ZA200600378A ZA200603781B (en) 2003-11-28 2006-05-10 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepinium maleate or tosylate as antipsychotics
IL175663A IL175663A0 (en) 2003-11-28 2006-05-16 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics
MA29055A MA28177A1 (fr) 2003-11-28 2006-05-24 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate ou tosylate en tant qu'agents antipsychotiques
IS8500A IS8500A (is) 2003-11-28 2006-06-08 7-[4-(4-klórbensýloxý)bensensúlfónýl]-8-metoxý-3-metýl-2,3,4,5-tetrahýdró-1H-3-bensasepíníummaleat eða tósýlat sem sefandi efni
NO20062970A NO20062970L (no) 2003-11-28 2006-06-26 7-[4-(4-klorobenzyloksy)benzensulfonyl]-8-metoksy-3-metyl-2,3,4,5-tetrahydro-1 H-3-benzazepiniummaleat eller tosyslat som antipsykotia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0327740.7A GB0327740D0 (en) 2003-11-28 2003-11-28 Novel compounds

Publications (1)

Publication Number Publication Date
GB0327740D0 true GB0327740D0 (en) 2003-12-31

Family

ID=29798028

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0327740.7A Ceased GB0327740D0 (en) 2003-11-28 2003-11-28 Novel compounds

Country Status (18)

Country Link
US (1) US20070275948A1 (https=)
EP (1) EP1687279A1 (https=)
JP (1) JP2007512285A (https=)
KR (1) KR20060103322A (https=)
CN (1) CN1906170A (https=)
AR (1) AR046719A1 (https=)
AU (1) AU2004293179A1 (https=)
BR (1) BRPI0417029A (https=)
CA (1) CA2547444A1 (https=)
GB (1) GB0327740D0 (https=)
IL (1) IL175663A0 (https=)
IS (1) IS8500A (https=)
MA (1) MA28177A1 (https=)
NO (1) NO20062970L (https=)
RU (1) RU2006122959A (https=)
TW (1) TW200528433A (https=)
WO (1) WO2005051916A1 (https=)
ZA (1) ZA200603781B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0510599D0 (en) * 2005-05-24 2005-06-29 Glaxo Group Ltd Novel compounds
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
JP5989965B2 (ja) * 2008-01-08 2016-09-07 メルク シャープ エンド ドーム リミテッド ２−｛４−［（３ｓ）−ピペリジン−３−イル］フェニル｝−２ｈ−インダゾール−７−カルボキサミドの薬学的に許容される塩
CA2970502A1 (en) * 2014-12-12 2016-06-16 The Schepens Eye Research Institute, Inc. Gdnf induction for the treatment of retinal disorders
US11225487B2 (en) 2017-02-17 2022-01-18 Trevena, Inc. 7-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the same
US20210347758A1 (en) 2018-10-03 2021-11-11 Tesaro, Inc. Crystalline Forms of Niraparib Freebase
JP2023546729A (ja) * 2020-10-27 2023-11-07 トレベナ・インコーポレイテッド デルタオピオイドモジュレーターの結晶形及び非晶形
CN115998724B (zh) * 2023-03-28 2023-06-16 中国人民解放军军事科学院军事医学研究院 布洛芬在抗幻觉作用药物中的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005518414A (ja) * 2001-12-21 2005-06-23 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー ドーパミン受容体のモジュレーターとしての７−スルホニル−３−ベンゾアゼピン誘導体およびｃｎｓ障害の治療のためのその使用
KR20040081201A (ko) * 2002-02-13 2004-09-20 글락소 그룹 리미티드 항정신병제로서 벤젠술폰아미드 유도체
AR040126A1 (es) * 2002-05-29 2005-03-16 Glaxo Group Ltd Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento

Also Published As

Publication number Publication date
US20070275948A1 (en) 2007-11-29
JP2007512285A (ja) 2007-05-17
KR20060103322A (ko) 2006-09-28
AR046719A1 (es) 2005-12-21
RU2006122959A (ru) 2008-01-10
CN1906170A (zh) 2007-01-31
ZA200603781B (en) 2007-09-26
BRPI0417029A (pt) 2007-02-06
IL175663A0 (en) 2006-09-05
AU2004293179A1 (en) 2005-06-09
MA28177A1 (fr) 2006-09-01
WO2005051916A1 (en) 2005-06-09
IS8500A (is) 2006-06-08
TW200528433A (en) 2005-09-01
NO20062970L (no) 2006-08-21
EP1687279A1 (en) 2006-08-09
CA2547444A1 (en) 2005-06-09

Similar Documents

Publication Publication Date Title
GB0308114D0 (en) Novel compounds
GB0305918D0 (en) Novel compounds
GB0308186D0 (en) Novel compounds
GB0308185D0 (en) Novel compounds
GB0304424D0 (en) Novel compounds
GB0308333D0 (en) Novel compounds
EP1596860A4 (en) NEW CONNECTIONS
GB0327740D0 (en) Novel compounds
GB0305426D0 (en) Novel compounds
GB0302431D0 (en) Novel compounds
GB0302546D0 (en) Novel compounds
GB0304809D0 (en) Novel compounds
GB0306209D0 (en) Novel compounds
GB0306213D0 (en) Novel compounds
GB0305722D0 (en) Novel compounds
GB0305688D0 (en) Novel compounds
GB0305687D0 (en) Novel compounds
GB0305586D0 (en) Novel compounds
GB0305564D0 (en) Novel compounds
GB0306211D0 (en) Novel compounds
GB0305293D0 (en) Novel compounds
GB0305292D0 (en) Novel compounds
GB0305291D0 (en) Novel compounds
GB0305290D0 (en) Novel compounds
GB0305285D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)